The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer
Article in Scientific Reports (March 2024)
The most recent citing publications are shown below. View all 49 publications that cite this research output on Dimensions.
The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells
Article in Toxicology and Applied Pharmacology (March 2024)
La muerte celular inmunogénica como potencial tratamiento alternativo frente a la leishmaniasis
Article (July 2023)